2. Jointly with China Pharmaceutical University, Shanxi Institute of Traditional Chinese Medicine, National Research and Engineering Center of Traditional Chinese Medicine Compound, and other units, undertake the national "Eleventh Five-Year Plan" major scientific and technological special project "Yan Shu Variety Technical Transformation Project with a price of more than 500 million yuan". This move will greatly enhance the industrialization benefits of leading products in Zhendong, and expand the road for the multi-field development and industrialization of Chinese herbal medicines.
3. Cooperating with Institute of Medicinal Plants of China Academy of Medical Sciences, Tianjin University of Traditional Chinese Medicine, Institute of Traditional Chinese Medicine of Chinese Academy of Traditional Chinese Medicine, Shanxi College of Traditional Chinese Medicine, Shanxi Institute of Traditional Chinese Medicine, etc., * * * undertook the national science and technology support plan project "Optimization and upgrading of standardized planting base of genuine medicinal material Sophora Flavescentis and research and development project of series products". This will make Zhendong's product quality more competitive in the market, and also create a new way for the cultivation and purification of Chinese herbal medicines in China.
4. Together with Shanxi Institute of Traditional Chinese Medicine, establish the technical platform of Zhendong Modernization Research Center of Traditional Chinese Medicine, and carry out research and development of new Chinese medicine such as Spatholobus suberectus freeze-dried powder for injection; Together with the Institute of Toxicology and Drugs of the Academy of Military Medical Sciences, a technical platform for the research and development of innovative preparations-sustained and controlled release preparations was established; Establish cooperation points with international partners and jointly establish Zhendong China-Australia Molecular Medicine Research Center at the University of Adelaide, Australia; In May of this year, they started the clinical study of compound Sophora flavescens injection in the United States in conjunction with Chinese Academy of Traditional Chinese Medicine, and developed a liposome preparation platform with Agre Search Co., Ltd. in the United States. 165438+1On October 2nd, the scientific research office established by Shanxi Zhendong Group and Chinese Academy of Traditional Chinese Medicine in the Cancer Research Center of American Institute of Health was officially put into operation this month. This is the first time that a national research institution has been listed in the United States to carry out research on traditional Chinese medicine, and it is also the first time that China enterprises, especially private enterprises, have cooperated with authoritative domestic research institutions to carry out research on traditional Chinese medicine in national research institutions in the United States. What's more striking is that at the preparatory meeting of the International Union for the Treatment of Tumors with Traditional Chinese Medicine held the next day, Shanxi Zhendong Group became the only pharmaceutical company member in China. Zhendong, shoulder that responsibility and mission of revitalizing China's traditional medicine, step onto the international stage. Zhang Boli, president of Chinese Academy of Traditional Chinese Medicine and academician of China Academy of Engineering, spoke highly of Zhendong's platform for internationalization of Chinese medicine, which provided a successful example for Chinese medicine enterprises to go international.
5.20 1 1, the company builds a domestic pharmaceutical industry research and development network. At present, a scientific research network of Zhendong-Shanxi College of Traditional Chinese Medicine-Shanxi University-Shanxi Medical University has been established. On this basis, it has also established cooperative relations with China Pharmaceutical University, Shenyang Pharmaceutical University, Shanghai Medical Engineering College, Shanghai Second Military Medical University, Peking University Pharmaceutical College and Tianjin Pharmaceutical Research Institute. On the basis of Shanxi Medical Research Network, we have completed the construction of four R&D networks: Beijing-Tianjin, Northeast China, Suzhou-Shanghai and Sichuan-Guangdong, strengthened Industry-University-Research cooperation with universities and research institutes, refined the work of various project departments, and formed a domestic R&D cooperation network with domestic and foreign universities and institutions as the core, such as Shanghai Medical Research Institute, Beijing Research Institute, National Cancer Research Center of the United States, Adelaide University of Australia and Shenyang Pharmaceutical University, which provided a networking platform and a networking platform for the research and development of Chinese medicine industry.
6. Enterprises have joined forces with universities and research institutes, actively exchanged talent information, formed a joint force of talent training and scientific and technological research, and improved the scientific research and technological innovation capabilities of enterprises. The company has carried out extensive projects and technical cooperation with more than 40 scientific research institutions, and has achieved fruitful results in undertaking projects and project cooperation, which has effectively promoted Industry-University-Research's ability of integration and innovation, and also enabled Zhendong to leap to a new level and integrate into the forefront of international scientific research.